The VL3 Videolaryngoscope for Elective Tracheal Intubation in Adults

January 30, 2020 updated by: Giuseppe Pascarella, Campus Bio-Medico University

The VL3 Videolaryngoscope for Elective Tracheal Intubation in Adults: a Prospective Pilot Study

We conducted an observational prospective pilot study to assess the efficacy of the VL3 videolaryngoscope for routinely tracheal intubation in 56 adults, in terms of successful rate, no. attempts and manoeuvre duration, including both normal and difficult airways.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Roma, Italy
        • Università Campus Biomedico

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients candidates for general anesthesia in elective surgery
  • Age over 18 years
  • ASA physical status I-III.

Exclusion Criteria:

  • Paediatric population
  • ASA physical status IV
  • Emergency tracheal intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: VL3
Tracheal intubation with VL3 videolaryngoscope
Tracheal Intubation aided by VL3 Videolaryngoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tracheal intubation rate
Time Frame: 30 minutes
successful tracheal intubation rate using VL3 video laryngoscope
30 minutes
Number of attempts
Time Frame: 30 minutes
Number of attempts for a successful tracheal intubation
30 minutes
Total time of intubation
Time Frame: 15 minutes
Time needed to perform a tracheal intubation from the insertion of VL3 video laryngoscope into the patient mouth
15 minutes
Time to glottis visualization
Time Frame: 15 minutes
Time needed to visualize the glottis from the insertion of VL3 video laryngoscope into the patient mouth
15 minutes
Cormack-Lehane grade
Time Frame: 15 minutes
Cormack-Lehane grade observed at videolaryngoscopy
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Need for external laryngeal pressure
Time Frame: 15 minutes
Need for external laryngeal pressure during laryngoscopy
15 minutes
Presence of post-laryngoscopy side effects
Time Frame: 3 days
Presence of post-laryngoscopy side effects (bleeding, postoperative sore throat and/or dysphonia)
3 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 4, 2018

Primary Completion (ACTUAL)

April 1, 2019

Study Completion (ACTUAL)

April 1, 2019

Study Registration Dates

First Submitted

January 30, 2020

First Submitted That Met QC Criteria

January 30, 2020

First Posted (ACTUAL)

February 5, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 5, 2020

Last Update Submitted That Met QC Criteria

January 30, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 82/18 OSS ComET CBM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult Airway Intubation

Clinical Trials on Videolaryngoscopy with VL3

3
Subscribe